Aminoglycoside uptake, stress, and potentiation in Gram-negative bacteria: new therapies with old molecules

Microbiol Mol Biol Rev. 2023 Dec 20;87(4):e0003622. doi: 10.1128/mmbr.00036-22. Epub 2023 Dec 4.

Abstract

SUMMARYAminoglycosides (AGs) are long-known molecules successfully used against Gram-negative pathogens. While their use declined with the discovery of new antibiotics, they are now classified as critically important molecules because of their effectiveness against multidrug-resistant bacteria. While they can efficiently cross the Gram-negative envelope, the mechanism of AG entry is still incompletely understood, although this comprehension is essential for the development of new therapies in the face of the alarming increase in antibiotic resistance. Increasing antibiotic uptake in bacteria is one strategy to enhance effective treatments. This review aims, first, to consolidate old and recent knowledge about AG uptake; second, to explore the connection between AG-dependent bacterial stress and drug uptake; and finally, to present new strategies of potentiation of AG uptake for more efficient antibiotic therapies. In particular, we emphasize on the connection between sugar transport and AG potentiation.

Keywords: Gram-negative bacteria; aminoglycosides; antibiotic potentiation; antibiotic resistance; stress adaptation.

Publication types

  • Review

MeSH terms

  • Aminoglycosides* / pharmacology
  • Aminoglycosides* / therapeutic use
  • Anti-Bacterial Agents* / pharmacology
  • Anti-Bacterial Agents* / therapeutic use
  • Bacteria
  • Drug Resistance, Multiple, Bacterial
  • Gram-Negative Bacteria

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents